Impact of Policy Changes for Anemia Care in Hemodialysis Examined
Recommended erythropoietin-stimulating agent dosing changes for anemia care in adults undergoing hemodialysis led to lower erythropoietin-stimulating agent use and lower hemoglobin levels.